Johnson & Johnson COVID-19 Vaccine Shows up to 85 Percent Effectiveness against Hospitalisation in South Africa While Omicron is Dominant
- EMEA Innovative Medicine
- Johnson & Johnson COVID-19 Vaccine Shows up to 85 Percent Effectiveness against Hospitalisation in South Africa While Omicron is Dominant
Johnson & Johnson COVID-19 Vaccine Shows up to 85 Percent Effectiveness against Hospitalisation in South Africa While Omicron is Dominant
- X (Twitter)
Copy link